(PharmaNewsWire.Com, June 30, 2020 ) The Nerve Repair and Regeneration Market is estimated to register a CAGR of 12.9% to reach USD 10.6 billion by 2022 from USD 5.8 billion in 2017. The increasing incidence of neurological disorders and technological advancements in nerve repair and regeneration products are the major factors driving the growth of the nerve repair and regeneration market.
The internal neurostimulation devices segment commanded the largest share of the neurostimulation and neuromodulation devices market in 2017 Based on type, the neurostimulation and neuromodulation devices market is segmented into internal and external neurostimulation devices. The internal neurostimulation devices segment accounted for the larger market share in 2017. These devices help in reducing post-surgical complications and length of hospital stay as well as enable long-term cost savings. Such advantages associated with internal neurostimulation devices are driving their adoption in the market.
Hospitals & clinics are the fastest-growing end users of the nerve repair and regeneration market By end user, the nerve repair and regeneration market is segmented into hospitals & clinics and ambulatory surgery centers. The hospitals & clinics segment accounted for the largest market share in 2017 and is projected to register the highest growth during the forecast period. A large number of nerve repair and neurological procedures performed in hospitals and the growing number of hospitals & clinics, especially in emerging countries, are some of the key factors driving the growth of the nerve repair and regeneration market for this end-user segment.
North America will continue to dominate the nerve repair and regeneration market during the study period By region, the nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest market share in 2017. Factors such as the increasing prevalence of neurological diseases, rapid growth in the geriatric population, favorable reimbursement policies, and the high healthcare expenditure in the region are supporting the growth of the nerve repair and regeneration market in North America.
Prominent players in the nerve repair and regeneration market include AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), and Polyganics (Netherlands).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: